about
Drug Delivery Innovations for Enhancing the Anticancer Potential of Vitamin E Isoforms and Their DerivativesInduction of caspase-independent programmed cell death by vitamin E natural homologs and synthetic derivativesVitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogsPhenoxodiol, an anticancer isoflavene, induces immunomodulatory effects in vitro and in vivo.Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasisSelective activation of TNFR1 and NF-κB inhibition by a novel biyouyanagin analogue promotes apoptosis in acute leukemia cells.In vitro study on the antioxidant activity of a polyphenol-rich extract from Pinus brutia bark and its fractions.Dietary retinoids and carotenoids in rodent models of mammary tumorigenesis.Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage.The dietary anticancer agent ellagic acid is a potent inhibitor of DNA topoisomerases in vitro.Vernonia kotschyana roots: therapeutic potential via antioxidant activity.Reversal of ER-β silencing by chromatin modifying agents overrides acquired tamoxifen resistance.A preliminary RAPD-PCR analysis of Cimicifuga species and other botanicals used for women's health.Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer.Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells.Betulinic acid reduces ultraviolet-C-induced DNA breakage in congenital melanocytic naeval cells: evidence for a potential role as a chemopreventive agent.The soy isoflavone daidzein improves the capacity of tamoxifen to prevent mammary tumours.Altered phosphorylation, biosynthesis and degradation of the 170 kDa isoform of topoisomerase II in amsacrine-resistant human leukemia cells.Molecular clustering via knowledge mining from biomedical scientific corporaThe effects of applying cell-suppression and perturbation to aggregated genetic dataSolubilization and stabilization of carotenoids using micelles: Delivery of lycopene to cells in cultureThe effect of topoisomerase inhibitors on the expression of differentiation markers and cell cycle progression in human K-562 leukemia cellsThe phosphoform of the regulatory subunit RII of cyclic AMP-dependent protein kinase possesses intrinsic topoisomerase activitySelection of cancer chemopreventive agents based on inhibition of topoisomerase II activityIsolation of isoflavones from soy-based fermentations of the erythromycin-producing bacterium Saccharopolyspora erythraeaGenistein induces apoptosis and topoisomerase II-mediated DNA breakage in colon cancer cellsA metabolite of equine estrogens, 4-hydroxyequilenin, induces DNA damage and apoptosis in breast cancer cell linesGenistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells
P50
Q26824259-CBBA51E1-3C4D-4E93-A544-77DE6BC4EAACQ28273185-343D478C-B2A7-4C3E-9135-09EDE3BAC18EQ28282070-3C8E17CF-E302-47E2-A1FA-CD9BD592760DQ35893432-89EBB866-3D84-4F0B-AB9A-E973F5939149Q35937934-9E282247-6259-42D6-8169-2B099B6CDD68Q35995213-EAD5D4F9-B182-4DE5-BC23-28D21D40E1C9Q37323296-A1882913-2B50-4857-97A1-4898258E2B91Q38529255-CF234FCE-1E6C-4A78-B334-01EBD32031ECQ38531943-AB3CA91E-CE9B-4305-AA26-9189FC929C92Q38532039-D1E4BCCA-7ADC-4210-B3AE-05AC9B60A644Q38938607-E7FE3816-3EBE-488A-81F2-1A2A36BD4C9FQ39141703-607F8955-4DF8-4E3B-AFC1-469C0D680177Q39397872-A302EC1C-B26D-43B8-9F8F-35467FFE0A51Q40586177-A20D595F-81E0-4516-8A78-EDD3FF3551B7Q40614935-DDDD5D46-652D-4029-9DBC-FA8519E1C506Q43595330-3471206C-4E5A-4023-9BD4-ACB69403993AQ45287299-E3E68DCF-6EAB-434E-89FC-44E430F763E2Q54240300-E49DB453-878C-4416-BD15-693B89B6F4C9Q62747233-F5FCAF50-1B03-4E7E-A668-3D39E6A824ACQ62747317-155C4971-B408-4C86-AF1A-7BCCE67EAC9BQ63339736-23A8820D-FD6E-4A5C-9762-3EC57C0FC015Q67506028-BDDAE492-1211-4E3A-9563-7C087A7E2C76Q68939913-A27897E3-E914-4A92-948B-452180EF2F53Q73109350-34CB00AD-3778-4EA0-B244-C6E80DFC4551Q73367959-DEE5B64D-2021-4F02-9C9F-510DE282929CQ73670885-1C41A231-D6DE-4925-B608-A165E3560EA2Q73797995-0B2B0A0F-5764-4DD7-8613-A2D195B7EED0Q74450949-91A00AB5-4A36-41C6-A1F0-D96D55750F5F
P50
description
researcher ORCID ID = 0000-0003-0365-1821
@en
name
Andreas I Constantinou
@ast
Andreas I Constantinou
@en
Andreas I Constantinou
@es
Andreas I Constantinou
@nl
type
label
Andreas I Constantinou
@ast
Andreas I Constantinou
@en
Andreas I Constantinou
@es
Andreas I Constantinou
@nl
prefLabel
Andreas I Constantinou
@ast
Andreas I Constantinou
@en
Andreas I Constantinou
@es
Andreas I Constantinou
@nl
P1153
7005140598
P31
P496
0000-0003-0365-1821